Matthew M. Walsh - 31 Mar 2023 Form 4 Insider Report for Organon & Co. (OGN)

Role
Chief Financial Officer
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Matthew M. Walsh
Issuer symbol
OGN
Transactions as of
31 Mar 2023
Net transactions value
-$61,327
Form type
4
Filing time
04 Apr 2023, 20:21:21 UTC
Previous filing
15 Nov 2022
Next filing
08 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise $0 +7,753 +24% $0.000000 39,459 31 Mar 2023 Direct
transaction OGN Common Stock Tax liability $61,327 -2,656 -6.7% $23.09 36,803 31 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -7,753 -33% $0.000000 15,507 31 Mar 2023 Common Stock 7,753 Direct F1, F2
transaction OGN Restricted Stock Units Award $0 +36,139 $0.000000 36,139 31 Mar 2023 Common Stock 36,139 Direct F3, F4
transaction OGN Stock Option (right to buy) Award $0 +129,770 $0.000000 129,770 31 Mar 2023 Common Stock 129,770 $23.52 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock.
F2 On March 31, 2023, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2024 and March 31, 2025.
F3 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU.
F4 These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026.
F5 The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026.